SentinusAI® Goes Live: Ainnocence’s AI Platform Turns Sequence Data Into Discovery Decisions in Days
The AI platform for therapeutic antibody and biologics discovery is now open for subscription. SAN FRANCISCO , CA, UNITED STATES, March 25, 2026 /EINPresswire.com/ -- The Challenge Therapeutic antibody development still depends heavily on structural …